We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

410 hedge funds and large institutions have $2.43B invested in Viking Therapeutics in 2026 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 156 increasing their positions, 117 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

239% more call options, than puts

Call options by funds: $241M | Put options by funds: $71M

33% more repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 117

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

0.3% less ownership

Funds ownership: 63.64% → 63.34% (-0.3%)

4% less capital invested

Capital invested by funds: $2.53B → $2.43B (-$108M)

4% less first-time investments, than exits

New positions opened: 66 | Existing positions closed: 69

3% less funds holding

Funds holding: 424 → 410 (-14)

Holders
410
Holders Change
-14
Holders Change %
-3.3%
% of All Funds
5.05%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
66
Increased
156
Reduced
117
Closed
69
Calls
$241M
Puts
$71M
Net Calls
+$170M
Net Calls Change
-$57.9M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$64.2M
2
American Century Companies
American Century Companies
Missouri
+$57M
3
Raymond James Financial
Raymond James Financial
Florida
+$37.1M
4
VPC
Vestal Point Capital
New York
+$29.4M
5
UBS Group
UBS Group
Switzerland
+$13.3M

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$24.2M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$23.1M
3
ECM
ExodusPoint Capital Management
New York
-$21M
4
AGP
Artia Global Partners
Florida
-$17.3M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
SF
101
Summit Financial
New Jersey
$1.99M +$128K +3,997 +7%
IA
102
IFP Advisors
Florida
$1.97M -$35.5K -1,105 -2%
Envestnet Asset Management
103
Envestnet Asset Management
Illinois
$1.96M +$441K +13,729 +30%
DIA
104
Dana Investment Advisors
Wisconsin
$1.94M +$121K +3,763 +7%
DCM
105
DAFNA Capital Management
California
$1.94M – – –
Rockefeller Capital Management
106
Rockefeller Capital Management
New York
$1.86M +$132K +4,103 +8%
CRC
107
Curi RMB Capital
Illinois
$1.84M +$51.6K +1,606 +3%
TC
108
TwinBeech Capital
New York
$1.83M +$1.8M +56,100 New
PA
109
Profund Advisors
Maryland
$1.79M -$29.1K -904 -2%
DekaBank Deutsche Girozentrale
110
DekaBank Deutsche Girozentrale
Germany
$1.74M – – –
WB
111
WesBanco Bank
West Virginia
$1.69M – – –
New York State Common Retirement Fund
112
New York State Common Retirement Fund
New York
$1.69M – – –
Commonwealth Equity Services
113
Commonwealth Equity Services
Massachusetts
$1.67M +$33.8K +1,053 +2%
HT
114
Headlands Technologies
Illinois
$1.6M +$601K +18,711 +61%
BPC
115
Banque Pictet & Cie
Switzerland
$1.58M +$433K +13,466 +38%
VGA
116
Vanguard Global Advisers
Pennsylvania
$1.54M +$1.52M +47,246 New
PFSRSONJ
117
Police & Firemen's Retirement System of New Jersey
New Jersey
$1.53M +$38.3K +1,191 +3%
Zurich Cantonal Bank
118
Zurich Cantonal Bank
Switzerland
$1.52M +$322K +10,009 +27%
Treasurer of the State of North Carolina
119
Treasurer of the State of North Carolina
North Carolina
$1.52M +$32.1K +998 +2%
Janus Henderson Group
120
Janus Henderson Group
United Kingdom
$1.49M – – –
PM
121
Prosight Management
Texas
$1.46M +$1.45M +45,000 New
FISPB
122
Fideuram - Intesa Sanpaolo Private Banking
$1.43M -$3.23M -100,573 -70%
EAM
123
Erste Asset Management
Austria
$1.41M – – –
1CM
124
1492 Capital Management
Wisconsin
$1.34M -$1.32K -41 -0.1%
QCM
125
Quantinno Capital Management
New York
$1.34M +$215K +6,688 +19%
3 4
5
6 7

VKTX Hedge Fund Activity: Q1 2026 in Review

410 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2026, worth a combined $2.43B — down 4.3% from $2.53B a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of VKTX and 66 opened new positions — a net loss of 3 holders — while 117 trimmed existing stakes and 156 added.

The largest buyer was Two Sigma Investments, adding an estimated $64.2M. The largest seller was Jane Street, cutting an estimated $24.2M.

  • 410 institutional investors held Viking Therapeutics (VKTX) as of Q1 2026, down from 424 in Q4 2025.
  • Funds reported $2.43B of Viking Therapeutics stock for Q1 2026, down 4.3% quarter-over-quarter.
  • 66 funds opened new Viking Therapeutics positions in Q1 2026 and 69 closed out, a net change of -3 holders.
  • The largest Viking Therapeutics buyer in Q1 2026 was Two Sigma Investments, an estimated $64.2M added.
  • The largest Viking Therapeutics seller in Q1 2026 was Jane Street, an estimated $24.2M sold.

Based on aggregated 13F filings for Q1 2026.